(Q36626000)

15 August 2017

1 reference

title

Establishing risk of human experimentation with drugs: lessons from TGN1412. (English)

1 reference

15 August 2017

M J H Kenter

1

1 reference

15 August 2017

A F Cohen

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

368

1 reference

15 August 2017

issue

9544

1 reference

15 August 2017

page(s)

1387-1391

1 reference

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Healthy volunteer studies in Great Britain: the results of a survey into 12 months activity in this field

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Clinically significant adverse effects in a Phase 1 testing program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

A death in the laboratory: the politics of the Gelsinger aftermath

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Protecting research subjects--the crisis at Johns Hopkins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

TGN1412—a regulator's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

TGN1412: time to change the paradigm for the testing of new pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

London's disastrous drug trial has serious side effects for research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Regulation of immune responses by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Co-stimulatory agonists as immunological adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Crystal structure of a soluble CD28-Fab complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

T cell inactivation and cytokine deviation promoted by anti-CD3 mAbs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Non-FcR-binding, humanized anti-CD3 antibody Hu291 induces apoptosis of human T cells more effectively than OKT3 and is immunosuppressive in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in "human immune system" Rag2(-/-)gammac(-/-) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

CD28 signaling in neutrophil induces T-cell chemotactic factor(s) modulating T-cell response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

Immunobiology of CD28 expression on human neutrophils. I. CD28 regulates neutrophil migration by modulating CXCR-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969562-7

7 January 2021

10.1016/S0140-6736(06)69562-7

Identifiers

DOI

1 reference

15 August 2017

1 reference